Cargando…
LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1
One of the characteristics of leukemia is that it contains multiple rearrangements of signal transduction genes and overexpression of non-mutant genes, such as transcription factors. As an important regulator of hematopoietic stem cell development and erythropoiesis, LMO2 is considered an effective...
Autores principales: | Lu, Lihui, Wang, Jianwei, Fang, Fang, Guo, Ailian, Jiang, Shuting, Tao, Yanfang, Zhang, Yongping, Li, Yan, Zhang, Kunlong, Zhang, Zimu, Zhuo, Ran, Chu, Xinran, Li, Xiaolu, Tian, Yuanyuan, Ma, Li, Sang, Xu, Chen, Yanling, Yu, Juanjuan, Yang, Yang, Cao, Haibo, Gao, Jizhao, Lu, Jun, Hu, Shaoyan, Pan, Jian, He, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423285/ https://www.ncbi.nlm.nih.gov/pubmed/37573405 http://dx.doi.org/10.1038/s41419-023-06039-w |
Ejemplares similares
-
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
por: Zhang, Kunlong, et al.
Publicado: (2022) -
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1
por: Zhang, Kunlong, et al.
Publicado: (2023) -
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
por: Ma, Li, et al.
Publicado: (2022) -
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
por: Sang, Xu, et al.
Publicado: (2022) -
LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)
por: Simonik, Elizabeth A., et al.
Publicado: (2016)